AVN-322
id:
avn-322-241-1118941
title:
AVN-322
text:
AVN-322 is a 5-hydroxytryptamine subtype 6 receptor antagonist manufactured by Avineuro Pharmaceuticals Inc. that could potentially be used to combat Alzheimer's disease and schizophrenia. AVN-322 also reverses the negative effects of scopolamine and MK-80. The compound is a sister drug to AVN-101 and AVN-211, two similar compounds under trial for treating Alzheimer's. Phase I trials for the drug were initiated in 2009 by Avineuro, and completed in the spring of 2010. The trials showed that AVN-
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/AVN-322
date created:
date modified:
2023-03-14T09:17:10Z
main entity:
{"identifier":"Q117198161","url":"https://www.wikidata.org/entity/Q117198161"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/4a/AVN-322.svg","width":570,"height":425}
fields total:
13
integrity:
15